Tecnologías sanitarias
Empresas argentinas dedicadas a un sector: tecnologías sanitarias
Estas Empresas argentinas operan en el mismo sector, tecnologías sanitarias. Incluyen el precio, el cambio y otras estadísticas para ayudarle a obtener la máxima información. La lista contiene acciones para cualquier tipo de estrategia: desde colosos de gran capitalización como ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), las principales ganadoras como MERCK & CO INC CEDEAR EAC 5 RE 1 (USD) y muchas más. Filtre la lista y compruebe el rendimiento de las empresas según le convenga.
Símbolo | Capitalización de mercado | Precio | Cambio % | Volumen | Volumen relativo | P/B | BPA dil. TTM | Crecimiento BPA dil. TTM YoY | Rendimiento del dividendo % TTM | Calificación de los analistas |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 768,75 T ARS | 14,250 USD | −1,72% | 1,19 K | 2,38 | 110,59 | 124,85 ARS | +178,70% | 0,41% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 768,75 T ARS | 14.950,000 ARS | −1,64% | 8,53 K | 1,49 | 119,74 | 124,85 ARS | +564,33% | 0,41% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 359,16 T ARS | 9,920 USD | −3,22% | 2,21 K | 1,84 | 31,32 | 306,92 ARS | +50,08% | 2,14% | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 359,16 T ARS | 10.450,000 ARS | −0,48% | 15,45 K | 2,07 | 34,05 | 306,92 ARS | +257,75% | 2,14% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 359,16 T ARS | 1.300,000 ARS | −2,26% | 9 | 1,29 | — | — | — | — | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 313,47 T ARS | 17,600 USD | −1,68% | 142 | 2,26 | 7,28 | 2.343,37 ARS | +18,73% | 1,88% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 313,47 T ARS | 18.625,000 ARS | −0,27% | 463 | 0,74 | 7,95 | 2.343,37 ARS | +183,01% | 1,88% | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 256,69 T ARS | 21,450 USD | +4,13% | 16 | 0,32 | 23,53 | 883,37 ARS | +319,19% | 1,62% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 256,69 T ARS | 21.650,000 ARS | +1,17% | 4,78 K | 2,63 | 24,51 | 883,37 ARS | +899,22% | 1,62% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 211,9 T ARS | 34,350 USD | −4,45% | 3 | 0,33 | 49,11 | 677,80 ARS | +64,44% | 1,59% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 211,9 T ARS | 36.000,000 ARS | 0,00% | 241 | 0,16 | 53,11 | 677,80 ARS | +291,99% | 1,59% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 207,93 T ARS | 25.700,000 ARS | −1,53% | 543 | 1,46 | 45,98 | 558,94 ARS | +251,94% | 0,15% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 201,39 T ARS | 30,000 USD | −0,33% | 16 | 0,73 | 46,14 | 629,98 ARS | +55,55% | 1,02% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 201,39 T ARS | 30.575,000 ARS | 0,00% | 60 | 0,17 | 48,53 | 629,98 ARS | +270,79% | 1,02% | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 200,33 T ARS | 25,000 USD | −11,97% | 2 | 1,05 | 2,79 | 8.672,72 ARS | +140,89% | 3,75% | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 200,33 T ARS | 26.550,000 ARS | 0,00% | 162 | 0,42 | 3,06 | 8.672,72 ARS | +474,20% | 3,75% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 196,97 T ARS | 6.500,000 ARS | 0,00% | 3 | 0,06 | 122,90 | 52,89 ARS | +386,62% | 0,00% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 172,96 T ARS | 4.610,000 ARS | −1,71% | 39 | 0,30 | 62,50 | 73,76 ARS | +137,74% | 0,00% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 149,51 T ARS | 9,200 USD | −3,16% | 81 | 1,80 | 35,79 | 249,09 ARS | −66,41% | 2,49% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 149,51 T ARS | 9.800,000 ARS | −0,31% | 544 | 0,36 | 39,34 | 249,09 ARS | −19,94% | 2,49% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 145,45 T ARS | 6,520 USD | +0,31% | 2,32 K | 0,95 | 26,92 | 234,71 ARS | +35,96% | 3,65% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 145,45 T ARS | 6.820,000 ARS | +0,59% | 15,35 K | 1,08 | 29,06 | 234,71 ARS | +224,10% | 3,65% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 117,12 T ARS | 23,500 USD | +1,29% | 13 | 0,71 | — | −50,65 ARS | −107,71% | 1,73% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 117,12 T ARS | 24.925,000 ARS | +1,22% | 61 | 0,22 | — | −50,65 ARS | −118,38% | 1,73% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 116,88 T ARS | 20,600 USD | +0,98% | 5 | 0,56 | — | −1.078,84 ARS | −253,68% | 2,28% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 116,88 T ARS | 20.075,000 ARS | −0,99% | 309 | 0,37 | — | −1.078,84 ARS | −466,33% | 2,28% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 108,17 T ARS | 22.225,000 ARS | +0,11% | 1,06 K | 1,42 | 33,05 | 672,48 ARS | +274,72% | 2,09% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 70,95 T ARS | 8,740 USD | +0,46% | 6 | 0,06 | 27,51 | 307,84 ARS | −37,30% | 3,58% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 70,95 T ARS | 9.160,000 ARS | −0,43% | 2,21 K | 0,97 | 29,76 | 307,84 ARS | +49,45% | 3,58% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 24,68 T ARS | 5.530,000 ARS | −0,54% | 86 | 0,37 | — | −689,04 ARS | −3,81% | 0,00% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 23,34 T ARS | 12,700 USD | −4,51% | 4 | 0,13 | 17,69 | 695,64 ARS | +96,62% | 0,00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 23,34 T ARS | 12.950,000 ARS | −0,38% | 707 | 0,84 | 18,62 | 695,64 ARS | +368,68% | 0,00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 16,78 T ARS | 2,330 USD | +1,30% | 5 | — | — | −262,17 ARS | +31,39% | 0,00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 16,78 T ARS | 2.430,000 ARS | +2,75% | 1,1 K | 0,31 | — | −262,17 ARS | −63,54% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 137,28 B ARS | 1.740,000 ARS | +2,35% | 8,07 K | 0,66 | 18,07 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5,06 B ARS | 117,750 ARS | −0,84% | 1 K | 0,11 | 27,59 | 4,27 ARS | +64,50% | 0,00% | — |